When mice at Fudan University in Shanghai received a gentle electrical pulse to their vagus nerve, something remarkable happened: their pain-related behaviors quieted, not just physically but emotionally. This subtle intervention, known as vagus nerve stimulation (VNS), has long hinted at promise for chronic pain, but the precise brain pathway behind its effect remained a mystery—until now. In a breakthrough study published in Nature Neuroscience, a team led by neuroscientist Hanfei Deng has mapped a previously unknown neural circuit that explains how a signal from the body’s periphery can calm pain deep within the brain.
Chronic pain affects hundreds of millions worldwide, often resisting conventional treatments. While VNS has been used clinically for epilepsy and depression, its application for pain relief has lacked a clear mechanism. Deng’s team set out to answer a fundamental question: How does stimulating a nerve in the neck influence the brain’s experience of pain? Their focus landed on the brainstem, specifically the caudal nucleus of the solitary tract (cNTS), the first major brain region that receives sensory input from the vagus nerve.
Through a series of precise experiments in adult mice, the researchers identified a distinct population of neurons in the cNTS that project directly to the periaqueductal gray (PAG)—a midbrain region long associated with pain control and emotional responses. When these neurons were activated, mice exhibited pain-like behaviors even without injury. When inhibited, those behaviors diminished. Crucially, vagus nerve stimulation was found to suppress activity in this cNTS-to-PAG pathway, effectively dialing down both the sensory and emotional dimensions of pain. Even more revealing, this pathway was shown to modulate dopamine signals in the nucleus accumbens, a brain area tied to motivation and pleasure, suggesting VNS doesn’t just block pain—it reshapes how the brain feels it.
The implications are profound. By pinpointing this specific circuit, the study opens the door to more targeted, effective therapies for conditions like fibromyalgia, chronic headaches, and inflammatory pain—without relying on opioids. With further research, VNS could be fine-tuned to activate this pathway with greater precision, potentially through non-invasive devices. As Deng puts it, “We identified a specific brainstem pathway, from the caudal nucleus of the solitary tract to the periaqueductal gray, that converts pain signals into behavioral and emotional responses.” This discovery doesn’t just explain how VNS works—it redefines how we think about pain itself, not as a static signal, but as a dynamic experience that can be rewired.